ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 780

$1.18M Total Retail Price of All Prescriptions

Rank: 35 out of 780

673 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 673 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 673 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 20,715 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 868 763 1 3
LEVOTHYROXINE SODIUM 735 613 2 5
FUROSEMIDE 702 585 3 7
POTASSIUM CHLORIDE 530 463 4 11
WARFARIN SODIUM 497 461 5 24
PRAVASTATIN SODIUM 493 383 6 9
LISINOPRIL 476 399 7 6
AMLODIPINE BESYLATE 468 392 8 4
HYDROCODONE-ACETAMINOPHEN 433 347 S3 9 1
METFORMIN HCL 431 388 10 8
SIMVASTATIN 431 383 10 2
LOSARTAN POTASSIUM 397 345 12 18
TRAMADOL HCL 333 278 13 15
CITALOPRAM HBR 316 292 14 23
MELOXICAM 308 265 15 16
TRAZODONE HCL 290 226 16 35
DONEPEZIL HCL 283 277 17 31
CLONIDINE HCL 282 211 18 28
METOPROLOL SUCCINATE 275 253 19 20
ATENOLOL 267 237 20 21
RANITIDINE HCL 261 228 21 39
SERTRALINE HCL 260 246 22 27
DIGOXIN 249 249 23 56
GLIMEPIRIDE 249 212 23 30
NAMENDA 241 241 25 46
ALLOPURINOL 235 189 26 29
METOPROLOL TARTRATE 228 220 27 19
GABAPENTIN 213 191 28 13
MIRTAZAPINE 210 189 29 58
DIVALPROEX SODIUM 207 194 30 119
ALENDRONATE SODIUM 206 190 31 44
BUMETANIDE 202 193 32 96
ALBUTEROL SULFATE 199 187 33 163
CARVEDILOL 198 156 34 14
CRESTOR 187 155 35 32
GLYBURIDE 183 155 R 36 101
PANTOPRAZOLE SODIUM 171 158 37 25
CIPROFLOXACIN HCL 170 148 38 49
CLOPIDOGREL 154 147 39 34
LOSARTAN-HYDROCHLOROTHIAZIDE 153 118 40 33
PREDNISONE 152 143 41 40
NEXIUM 149 93 42 22
VENLAFAXINE HCL ER 146 137 43 117
NIFEDIPINE ER 143 128 44 115
HYDROCHLOROTHIAZIDE 143 111 44 10
ADVAIR DISKUS 142 114 46 68
CYCLOBENZAPRINE HCL 140 75 R 47 42
ATORVASTATIN CALCIUM 132 115 48 12
LANTUS 126 108 49 71
LYRICA 121 99 50 52
KLOR-CON 8 120 95 51 194
CELEBREX 119 99 52 89
COLESTIPOL HCL 116 94 53 273
DIOVAN 115 104 54 55
ZOLPIDEM TARTRATE 115 86 54 17
PLAVIX 110 102 56 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 91 57 26
HYDRALAZINE HCL 104 75 58 54
MEGESTROL ACETATE 104 104 R 58 161
ACETAMINOPHEN-CODEINE 101 92 S3 60 116
SUCRALFATE 100 91 61 149
TAMSULOSIN HCL 99 87 62 36
METHYLPREDNISOLONE 98 79 63 92
EXELON 96 96 64 132
DIVALPROEX SODIUM ER 96 55 64 216
IPRATROPIUM-ALBUTEROL 95 95 66 214
MUPIROCIN 94 75 67 173
AMLODIPINE BESYLATE-BENAZEPRIL 93 76 68 50
RAMIPRIL 92 90 69 70
AZITHROMYCIN 92 75 69 38
ZIPRASIDONE HCL 90 71 71 264
SPIRIVA 89 85 72 72
PHENYTOIN SODIUM EXTENDED 87 61 73 128
PROPRANOLOL HCL 87 65 73 133
SINGULAIR 86 50 75 73
DICLOFENAC SODIUM 85 58 76 137
NITROFURANTOIN MONO-MACRO 82 78 77 247
DILTIAZEM ER 78 68 78 134
BYSTOLIC 78 62 78 118
CEFDINIR 77 60 80 180
CARBIDOPA-LEVODOPA 77 50 80 124
ISOSORBIDE MONONITRATE ER 76 69 82 60
MECLIZINE HCL 76 70 82 83
SPIRONOLACTONE 74 52 84 53
NOVOLIN 70-30 73 67 85 164
EVISTA 73 73 85 151
DOXYCYCLINE HYCLATE 72 53 87 103
CEPHALEXIN 71 65 88 105
AMITRIPTYLINE HCL 70 62 R 89 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 61 89 88
CLOTRIMAZOLE-BETAMETHASONE 70 59 89 166
CILOSTAZOL 69 69 92 229
WELCHOL 68 58 93 272
ESTRADIOL 66 45 R 94 122
RISPERIDONE 66 46 94 98
LEVETIRACETAM 64 29 96 130
VERAPAMIL ER 63 39 97 78
METHOCARBAMOL 63 54 R 97 84
NOVOLOG 61 45 99 158
JANUVIA 60 60 100 85
TRICOR 58 53 101 152
GEMFIBROZIL 57 47 102 104
INSULIN SYRINGE 55 33 103 80
GLIPIZIDE 55 44 103 74
PROMETHAZINE HCL 55 45 R 103 66
PROAIR HFA 54 38 106 62
ZETIA 54 36 106 94
METOCLOPRAMIDE HCL 54 47 106 102
CLINDAMYCIN HCL 53 44 109 271
TRAMADOL HCL-ACETAMINOPHEN 52 50 110 140
PAROXETINE HCL 52 40 110 69
FLUTICASONE PROPIONATE 52 34 110 41
LIDODERM 50 45 113 224
COLCRYS 50 36 113 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.